Neopharm
Profile
Organisation tracking is available to eligible accounts.
Profile narrative
Neopharm operates as a retail pharmacy chain in Russia, providing prescription medications, over‑the‑counter health products, and related wellness items to customers in Moscow and Saint Petersburg. The company maintains more than 110 pharmacy outlets across these two major cities, offering services that include dispensing prescriptions, managing loyalty programmes, and processing transactions through point‑of‑sale systems. Its core business centres on the sale of pharmaceutical goods and the provision of ancillary retail services such as health‑consultation advice and promotional programmes for repeat customers. Neopharm’s operational model relies on integrated digital infrastructure to support inventory management, prescription processing, and customer loyalty tracking. The firm serves urban consumers seeking convenient access to both essential medicines and broader health‑related products.
Neopharm’s distinguishing attributes include its focus on a loyalty‑driven retail approach and its dependence on computerized systems for prescription fulfilment and sales processing, as highlighted by the July 2025 cyberattack that temporarily disabled its IT networks and forced the closure of its stores. The attack, which also affected the larger Stolichki chain, disrupted prescription access, loyalty programme functionality, and point‑of‑sale operations, prompting the company to send staff home while restoration efforts proceeded. This incident followed a separate cyberattack on a national airline claimed by Ukrainian and Belarusian hacking groups, underscoring a broader trend of digital threats targeting Russian critical services. Neopharm is headquartered in Russia, although publicly available sources do not disclose its ownership structure or parent‑subsidiary relationships. The company’s scale and market presence are defined by its network of over 110 pharmacies in two of the country’s largest metropolitan areas, positioning it as a notable participant in the Russian retail pharmacy sector.
Incidents
1 incident linked to this organisation.